ShanX Medtech is awarded the MIT feasibility study
ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy.
This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally mapping out the strengths and weaknesses and the opportunities and risks of this project. With this project we will gain a deeper understanding of the necessary resources to implement said project and also what the chances of success are.
